Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 528821000036113 | Survanta (beractant 200 mg / 8 mL) intratracheal suspension, 1 x 8 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 528831000036110 | Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | Is a | beractant 200 mg/8 mL intratracheal suspension, 8 mL vial | true | Inferred relationship | Some | ||
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | has TPUU | Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | true | Inferred relationship | Some | 1 | |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | has TP | Survanta | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | Is a | True | Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR